(Q51890841)

17 April 2018

title

Predictors of cognitive decline after chemotherapy in breast cancer patients. (English)

1 reference

17 April 2018

1 reference

3

1 reference

17 April 2018

Nancy Pachana

4

1 reference

17 April 2018

author name string

Katharine J Vearncombe

1

1 reference

17 April 2018

Margaret Rolfe

2

1 reference

17 April 2018

Brooke Andrew

5

1 reference

17 April 2018

Geoffrey Beadle

6

1 reference

17 April 2018

language of work or name

English

0 references

publication date

27 August 2009

1 reference

17 April 2018

Journal of the International Neuropsychological Society

published in

1 reference

17 April 2018

volume

15

1 reference

17 April 2018

page(s)

951-962

1 reference

17 April 2018

issue

6

1 reference

17 April 2018

The reliability and stability of verbal working memory measures.

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709990567

7 January 2021

Test-retest reliability of a new form of the auditory verbal learning test (AVLT).

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709990567

7 January 2021

No indications of cognitive side-effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709990567

7 January 2021

Attentional fatigue following breast cancer surgery

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709990567

7 January 2021

Detecting significant change in neuropsychological test performance: a comparison of four models

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709990567

7 January 2021

A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer.

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709990567

7 January 2021

The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709990567

7 January 2021

Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709990567

7 January 2021

Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709990567

7 January 2021

Cognitive function in breast cancer patients prior to adjuvant treatment

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709990567

7 January 2021

Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709990567

7 January 2021

Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709990567

7 January 2021

Cognitive Function, Fatigue, and Menopausal Symptoms in Women Receiving Adjuvant Chemotherapy for Breast Cancer

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709990567

7 January 2021

Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma.

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709990567

7 January 2021

Short-term effects of treatment-induced hormonal changes on cognitive function in breast cancer patients: results of a multicenter, prospective, longitudinal study

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709990567

7 January 2021

The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study.

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709990567

7 January 2021

Renaming "chemobrain"

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709990567

7 January 2021

Cognitive impairment associated with adjuvant therapy in breast cancer

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709990567

7 January 2021

Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument.

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709990567

7 January 2021

Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709990567

7 January 2021

The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature.

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709990567

7 January 2021

A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709990567

7 January 2021

Relationship of hemoglobin levels to fatigue and cognitive functioning among cancer patients receiving chemotherapy.

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709990567

7 January 2021

The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709990567

7 January 2021

Cognitive impairments associated with breast cancer treatments: results from a longitudinal study

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709990567

7 January 2021

Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709990567

7 January 2021

Neuropsychological function in high-risk breast cancer survivors after stem-cell supported high-dose therapy versus standard-dose chemotherapy: evaluation of long-term treatment effects

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709990567

7 January 2021

Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709990567

7 January 2021

Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy.

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709990567

7 January 2021

Cognitive function after chemotherapy in adults with solid tumours

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709990567

7 January 2021

'Chemobrain' in breast carcinoma?: a prologue

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709990567

7 January 2021

Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709990567

7 January 2021

The hospital anxiety and depression scale

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709990567

7 January 2021

Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma.

1 reference

https://api.crossref.org/works/10.1017%2FS1355617709990567

7 January 2021

10.1017/S1355617709990567

Identifiers

DOI

1 reference

17 April 2018

PubMed ID

19709455

1 reference

17 April 2018